Merit Medical Systems (MMSI) Receives U.S. FDA 510(K) Clearance for Merit Laureate Guide Wire
Merit Medical Systems, Inc. (NASDAQ: MMSI) particularly in cardiology, radiology and gastroenterology, today announced that it has received 510(k) clearance from the FDA for the Merit Laureate hydrophilic guide wire.
"This 510(k) clearance from the FDA is the culmination of three years of challenging research that we believe will position Merit as a major player in a $150-200 million hydrophilic guide wire market," said Fred P. Lampropoulos, Merit's Chairman and Chief Executive Officer. "Over the next several years, we believe this product will be able to produce approximately $30 million in sales with gross margins exceeding current company averages."
"This product will be sold in both our cardiology and radiology sales points," Lampropoulos added. "Procedures that include drainage catheter access, dialysis catheter placement as well as difficult vascular access procedures commonly use hydrophilic guide wires."
The Merit Laureate guide wire is fabricated from a unique core nitinol wire, covered with a urethane jacket and coated with a proprietary process that produces a slippery surface. Features of the wire, including torquability and pushability, allow passage through tortuous anatomy.
The project, which was code-named "The Irish Project" is scheduled for worldwide release in January 2010.
Related Categories
Corporate NewsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
